Citigroup Portfolio holdings
Citigroup Inc., formed in 1998 through the landmark merger of Citicorp and Travelers Group, with roots tracing back to the 1812 founding of City Bank of New York, is a global financial powerhouse headquartered in New York City, managing trillions in assets. Operating in over 160 countries, Citigroup offers a broad spectrum of services, including consumer banking (via Citibank), investment banking, wealth management, and trading, serving millions of retail customers and major corporations, governments, and institutions worldwide. Under CEO Jane Fraser since 2021—the first woman to lead a major U.S. bank—Citigroup has focused on streamlining operations, exiting consumer banking in 13 markets to bolster its institutional and wealth management focus, while navigating post-2008 regulatory scrutiny and fines. Known for its vast global footprint and resilience through crises, Citigroup remains a key player in international finance, blending retail accessibility with high-stakes capital markets expertise.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$1.36B |
| 2 |
Invesco QQQ Trust
QQQ
|
+$353M |
| 3 |
ALXN
Alexion Pharmaceuticals
ALXN
|
+$334M |
| 4 |
JPMorgan Chase
JPM
|
+$251M |
| 5 |
Amazon
AMZN
|
+$235M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Russell 2000 ETF
IWM
|
+$713M |
| 2 |
Invesco WilderHill Clean Energy ETF
PBW
|
+$508M |
| 3 |
iShares iBoxx $ Investment Grade Corporate Bond ETF
LQD
|
+$474M |
| 4 |
Tesla
TSLA
|
+$460M |
| 5 |
Invesco Dorsey Wright Momentum ETF
PDP
|
+$363M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 12.39% |
| 2 | Financials | 8.32% |
| 3 | Consumer Discretionary | 6.71% |
| 4 | Healthcare | 6.14% |
| 5 | Communication Services | 4.98% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1851
Kulicke & Soffa
KLIC
$4.34B
| $4.42M | ﹤0.01% |
90,065
+43,942
| +95% | +$1.91M |
|
1852
Westlake Corp
WLK
$9.26B
| $4.42M | ﹤0.01% |
49,721
+44,484
| +849% | +$3.86M |
|
1853
Ligand Pharmaceuticals
LGND
$5.77B
| $4.41M | ﹤0.01% |
46,320
+37,536
| +427% | +$3.55M |
|
1854
AMC Global Media
AMCX
$450M
| $4.4M | ﹤0.01% |
82,785
+19,547
| +31% | +$1.07M |
|
1855
TG Therapeutics
TGTX
$8.19B
| $4.4M | ﹤0.01% |
91,307
+66,861
| +274% | +$3.21M |
|
1856
PVH
PVH
$4.07B
| $4.39M | ﹤0.01% |
41,581
-43,084
| -51% | -$4.26M |
|
|
CLR
1857
DELISTED
CONTINENTAL RESOURCES INC.
CLR
| $4.38M | ﹤0.01% |
169,490
+47,088
| +38% | +$1.1M |
|
1858
First Hawaiian
FHB
$3.41B
| $4.38M | ﹤0.01% |
160,075
+90,417
| +130% | +$2.43M |
|
1859
iShares MSCI All Country Asia ex Japan ETF
AAXJ
$3.51B
| $4.38M | ﹤0.01% |
47,261
-2,124
| -4% | -$204K |
|
1860
Allogene Therapeutics
ALLO
$625M
| $4.38M | ﹤0.01% |
123,961
+101,390
| +449% | +$3.42M |
|
1861
Associated Banc-Corp
ASB
$5.8B
| $4.36M | ﹤0.01% |
204,405
+145,030
| +244% | +$2.94M |
|
1862
iShares MSCI Australia ETF
EWA
$1.38B
| $4.36M | ﹤0.01% |
175,807
+96,968
| +123% | +$2.41M |
|
1863
Cytokinetics
CYTK
$10.6B
| $4.34M | ﹤0.01% |
186,746
+164,502
| +740% | +$3.51M |
|
1864
Virtu Financial
VIRT
$5.04B
| $4.33M | ﹤0.01% |
139,421
+89,414
| +179% | +$2.47M |
|
|
BPMC
1865
DELISTED
Blueprint Medicines
BPMC
| $4.31M | ﹤0.01% |
44,334
+30,032
| +210% | +$3M |
|
1866
Neogen
NEOG
$2.05B
| $4.3M | ﹤0.01% |
96,816
-17,446
| -15% | -$731K |
|
1867
PUT
VanEck Oil Services ETF
OIH
$1.97B
| $4.3M | ﹤0.01% |
22,500
-153,440
| -87% | -$28.9M |
|
1868
Myriad Genetics
MYGN
$476M
| $4.3M | ﹤0.01% |
141,057
+93,915
| +199% | +$2.67M |
|
1869
Q2 Holdings
QTWO
$3.78B
| $4.29M | ﹤0.01% |
42,857
+1,780
| +4% | +$221K |
|
|
SVC
1870
Service Properties Trust
SVC
$1.05B
| $4.29M | ﹤0.01% |
72,412
-9,495
| -12% | -$571K |
|
1871
VanEck Fallen Angel High Yield Bond ETF
ANGL
$3.07B
| $4.29M | ﹤0.01% |
134,275
+21,064
| +19% | +$676K |
|
|
DRNA
1872
DELISTED
Dicerna Pharmaceuticals, Inc.
DRNA
| $4.28M | ﹤0.01% |
167,339
+142,627
| +577% | +$3.64M |
|
1873
PUT
Sun Communities
SUI
$15.8B
| $4.28M | ﹤0.01% |
+28,500
| New | +$4.21M |
|
|
FOLD
1874
DELISTED
Amicus Therapeutics
FOLD
| $4.28M | ﹤0.01% |
432,795
+335,772
| +346% | +$5.2M |
|
1875
Insmed
INSM
$22.4B
| $4.27M | ﹤0.01% |
125,393
+426
| +0.3% | +$16.3K |
|
Similar funds
Citigroup's Q1 2021 Portfolio in Review
As of Q1 2021, Citigroup held 7,934 positions worth $155B, down 8.7% from $169B the previous quarter. Its ten largest holdings account for 21% of the portfolio.
Citigroup withdrew a net $23.7B in Q1 2021, closing 1,718 positions and reducing 2,980 holdings. Its most notable exit was PARSLEY ENERGY INC, an estimated $102M position sold in full.
By sector, the portfolio is most concentrated in Technology at 12% of assets, up from 10% a quarter earlier, followed by Financials and Consumer Discretionary.
Against the trend, Citigroup opened a new position in ProShares UltraPro Short QQQ worth $176M.
- Citigroup's largest Q1 2021 buy was ProShares UltraPro Short QQQ: 107,444 shares worth $176M.
- Citigroup added most to State Street SPDR S&P 500 ETF Trust in Q1 2021, an estimated $1.36B increase.
- Citigroup's biggest Q1 2021 reduction was iShares Russell 2000 ETF, cutting an estimated $713M.
- Citigroup fully exited PARSLEY ENERGY INC in Q1 2021, selling an estimated $102M.
- Citigroup's ten largest holdings make up 21% of its $155B portfolio in Q1 2021.
- Citigroup opened 527 new positions and closed 1,718 in Q1 2021.
- Citigroup's portfolio value fell 8.7% quarter-over-quarter to $155B.
Based on Citigroup's 13F filing for Q1 2021, filed 13 May 2021.